23andMe Holding Co. (NASDAQ:ME) Q1 2025 Earnings Call Transcript
Operator: Hello, and welcome to 23andMe's Fiscal Year 2025 First Quarter Financial Results Conference Call. As a reminder this call is being recorded.
23Andme Holding Co. (ME)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Euclidean Capital Jim Simons | 10,243,122 | $4,007,109 | 0.5% | |
| 2. | Millennium Management Israel Englander | 4,944,913 | $1,934,450 | +197% | 0% |
| 3. | Renaissance Technologies Jim Simons | 4,226,779 | $1,653,516 | -13% | 0% |
| 4. | Steel Partners Warren Lichtenstein | 2,095,493 | $819,757 | 1.03% | |
| 5. | Centiva Capital Karim Abbadi And Edward Mcbride | 635,600 | $248,647 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.41 | 11,467 | Director | 11,467 | 2022-03-10 | Filing | |
| $10.00 | 100,000 | Director | 100,000 | 2020-10-06 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.49 | 38,551 | Officer | 1,252,315 | 2024-05-02 | Filing | |
| $0.47 | 38,548 | Officer | 1,252,315 | 2024-04-18 | Filing | |
| $0.50 | 38,548 | Officer | 1,252,315 | 2024-04-04 | Filing | |
| $0.46 | 38,548 | Officer | 1,252,315 | 2024-03-21 | Filing | |
| $0.53 | 38,548 | Officer | 1,252,315 | 2024-03-07 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,554,104 | $20,603,174 | 0% | |
| 2. | 22,467,761 | $20,524,299 | 0% | |
| 3. | 19,455,681 | $17,704,670 | 15.86% | |
| 4. | 7,058,650 | $6,448,732 | 0% | |
| 5. | 5,736,198 | $5,240,017 | 0% |
News See All
23andMe Holding Co. (NASDAQ:ME) Q4 2024 Earnings Call Transcript
Operator: Hello, and welcome to 23andMe's Fiscal Year 2024 Fourth Quarter and Full-Year Financial Results Conference Call. As a reminder this call is being recorded.
20 Most Valuable Digital Health Companies In The US
In this article, we will be taking a look at the 20 most valuable digital health companies in the US.
23andMe Holding Co. (NASDAQ:ME) Q3 2024 Earnings Call Transcript
Operator: Hello, and welcome to 23andMe's Fiscal Year 2024 Third Quarter Financial Results Conference Call. As a reminder, this call is being recorded.
5 Most Promising Small-Cap Stocks According to Analysts
In this piece, we will take a look at the five most promising small-cap stocks according to analysts.
23andMe Holding Co. (NASDAQ:ME) Q2 2024 Earnings Call Transcript
Operator: Hello, and welcome to 23andMe's Fiscal Year 2024 Second Quarter Financial Results Conference Call. As a reminder, this call is being recorded.
23andMe Holding Co. (NASDAQ:ME) Q4 2023 Earnings Call Transcript
Operator: Hello, and welcome to 23andMe's Fiscal Year 2023 Fourth Quarter and Full Year Financial Results Conference Call. As a reminder, this call is being recorded.
23andMe Holding Co. (NASDAQ:ME) Q3 2023 Earnings Call Transcript
Operator: Good day, and welcome to 23andMe's Fiscal Year 2023 Third Quarter Financial Results Conference Call. At a reminder, this call is being recorded.
Top 25 Smartest Companies To Buy According To Hedge Funds
Surviving in the modern day corporate world is not for the faint of heart. Business is a ruthless endeavor, and shareholder and investor interest reign supreme for each company.
10 Penny Stocks That Can Grow Big in 2023
Numerous speculative asset classes, including cryptocurrency and penny stocks, have suffered at the hands of economic uncertainty this year.